ConSynance Therapeutics Reports Positive Phase 1 Results for CSTI-500 in Prader-Willi Syndrome Patients
30 mai 2023 10h00 HE
|
ConSynance Therapeutics
RENSSELAER, New York, May 30, 2023 (GLOBE NEWSWIRE) -- ConSynance Therapeutics, Inc., an emerging biopharmaceutical firm focused on developing novel therapies for rare central nervous system (CNS)...
Technology Advances in Senolytics 2023: Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells
26 mai 2023 05h53 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Technology Advances in Senolytics" report has been added to ResearchAndMarkets.com's offering. Senolytics is a relatively new field of development...
Atypical Teratoid Rhabdoid Tumors (ATRT) Pipeline Insights Report 2023 Featuring Novartis Pharmaceuticals, Ipsen Pharma, Chimerix, Exelixis, & Takeda Pharmaceuticals
23 mai 2023 08h58 HE
|
Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
Drafting Effective Pharmaceutical Patents Training Course
22 mai 2023 04h53 HE
|
Research and Markets
Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Drafting Effective Pharmaceutical Patents Training Course" conference has been added to ResearchAndMarkets.com's offering. The highly complex area of...
Global Active Pharmaceutical Ingredients Market Report 2023: Sector to Reach $386.2 Billion by 2032 with a 6.4% CAGR
05 mai 2023 04h48 HE
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredients Market 2022-2032 by Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region:...
Dalriada brings in former Evotec executive Adam Davenport to lead strategy execution as Chief R&D Officer
03 mai 2023 02h00 HE
|
Dalriada
TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today that it has strengthened its executive...
Small Molecule API Market Size to Surpass USD 246.22 billion by 2030, exhibiting a 6.8% CAGR
26 avr. 2023 06h17 HE
|
Fortune Business Insights
Pune, India, April 26, 2023 (GLOBE NEWSWIRE) -- The global small molecule API market size was USD 146.14 billion in 2022 and is projected to grow from USD 154.95 Billion in 2023 to USD 246.22...
Aptamers Global Market Report 2023: Growing Demand for High-Efficiency and Low-Cost Aptamers Presents Lucrative Opportunities
25 avr. 2023 06h53 HE
|
Research and Markets
Dublin, April 25, 2023 (GLOBE NEWSWIRE) -- The "Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type (DNA Aptamers, XNA Aptamers, RNA...
Provectus Biopharmaceuticals Announces Publication of Activity of Pharmaceutical-Grade Rose Bengal Sodium (RBS) Against Colistin-Resistant Gram-Negative Bacteria
20 avr. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
Colistin is used as last-resort treatment for bacterial infectionsProvectus’ RBS effectively inhibits growth of colistin-resistant G- bacteriaRBS also possesses rapid-killing feature KNOXVILLE, TN,...
Dalriada further strengthens small molecule discovery expertise with appointment of veteran Dr. Frosty Loechel as SVP Biology, Discovery Strategy group
19 avr. 2023 02h00 HE
|
Dalriada
TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today the appointment of Frosty Loechel,...